CLINICAL INK
Clinical Ink, Inc. provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol-specific eSource documents, as well as captures the data required by the protocol. The company also provides an electronic source record (ESR) for clinical trials that provides cleaner data. In addition, it offers hosting services. Clinical Ink was founded in 2006 and is based in Winston-Salem, North Carolina.
CLINICAL INK
Industry:
Clinical Trials Health Care Information Technology Mobile Devices Software
Founded:
2006-01-01
Address:
Winston Salem, North Carolina, United States
Country:
United States
Website Url:
http://www.clinicalink.com
Total Employee:
51+
Status:
Active
Contact:
336-714-7402
Total Funding:
34.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Sitelinks Search Box
Similar Organizations
Current Advisors List
Board_member
2018-01-01
Current Employees Featured
Edward S. Seguine CEO @ Clinical Ink
CEO
2012-01-01
Jonathan Andrus Chief Business Officer @ Clinical Ink
Chief Business Officer
2018-08-01
Doug Pierce President @ Clinical Ink
President
2006-11-01
Scott Miltenberger Chief Financial Officer @ Clinical Ink
Chief Financial Officer
2016-01-01
Christopher Crucitti Chief Commercial Officer @ Clinical Ink
Chief Commercial Officer
2021-05-01
Tommy Littlejohn President @ Clinical Ink
President
2006-04-01
Vikram Natarajan Vice President Of Product Development @ Clinical Ink
Vice President Of Product Development
2019-03-01
Tommy Littlejohn President @ Clinical Ink
President
2006-04-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-08 | Digital Artefacts | Digital Artefacts acquired by Clinical Ink | N/A |
Investors List
McKesson Ventures
McKesson Ventures investment in Venture Round - Clinical Ink
Novaquest Capital Management
Novaquest Capital Management investment in Private Equity Round - Clinical Ink
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Clinical Ink
Clayton Associates
Clayton Associates investment in Series C - Clinical Ink
FCA Venture Partners
FCA Venture Partners investment in Series C - Clinical Ink
F2 Ventures
F2 Ventures investment in Venture Round - Clinical Ink
MPM Capital
MPM Capital investment in Venture Round - Clinical Ink
FCA Venture Partners
FCA Venture Partners investment in Venture Round - Clinical Ink
FCA Venture Partners
FCA Venture Partners investment in Series B - Clinical Ink
Official Site Inspections
http://www.clinicalink.com Semrush global rank: 620.6 K Semrush visits lastest month: 71.93 K
Unable to get host informations!!!
More informations about "Clinical Ink"
About Us | Our Mission and Values | Clinical ink
Our therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a …See details»
Clinical Ink - Crunchbase Company Profile & Funding
Organization. Clinical Ink . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@clinicalink.com; Phone Number 336-714-7402; Clinical Ink, Inc. provides …See details»
Contract Research Organizations in Clinical Trials
By leveraging Clinical ink eSource technology, tools, and deep expertise in patient-centric research and complex therapeutic areas, CROs gain a significant advantage in setting themselves apart and outpacing the market. Secure more …See details»
Clinical ink - LinkedIn
Clinical ink is the global life science company that brings data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA ...See details»
Clinical Ink - Overview, News & Similar companies - ZoomInfo
Apr 1, 2024 Clinical Ink has announced that Andrew Kraus has joined the organization as Chief Technology Officer. Previously, Kraus served as Chief Operating Officer for World Care …See details»
Clinical ink Company Overview, Contact Details & Competitors
Global contract research organization (CRO) PPD has collaborated with clinical technology firm Clinical Ink to develop a systemic lupus erythematosus (SLE) assessment review process that …See details»
GI Partners Completes Acquisition of Clinical Ink - PR Newswire
Aug 26, 2020 Visit clinicalink.com. About GI Partners Founded in 2001, GI Partners is a private investment firm based in San Francisco, California. The firm has raised over $21 billion in …See details»
GI Partners Completes Acquisition of Clinical Ink
Aug 26, 2020 Visit clinicalink.com. About GI Partners Founded in 2001, GI Partners is a private investment firm based in San Francisco, California. The firm has raised over $21 billion in …See details»
GI Partners to Acquire Clinical Ink | News | GI Partners
Aug 4, 2020 Visit clinicalink.com. About GI Partners Founded in 2001, GI Partners is a private investment firm based in San Francisco, California. The firm has raised over $21 billion in …See details»
Working At Clinical Ink: Company Overview and Culture - Zippia
Mar 14, 2024 www.clinicalink.com. Organization Type. Private. CEO. Ed Seguine. Social Media. Clinical Ink, Inc. provides eSource solutions for the clinical trials industry. It offers SureSource, …See details»
Clinical Ink Ranked Among Fastest-Growing Companies in
Nov 17, 2021 Chris Crucitti Chief Commercial Officer Clinical Ink Phone: +1 917-743-0158 Email: chris.crucitti@clinicalink.com Release Summary Clinical Ink today announced it ranked …See details»
Privacy Policy - Clinical ink
Clinical Ink collects identifying information when you use the Products (including, without limitation, any clinicalink.com web pages or landing pages), and when you submit data through …See details»
Clinical Ink Acquires Digital Artefacts - Business Wire
Nov 8, 2021 Chris Crucitti Chief Commercial Officer Clinical Ink 917-743-0158 chris.crucitti@clinicalink.com. Release Summary. Clinical Ink acquires Digital Artefacts, …See details»
Clinical ink Selected for Global Late Phase Parkinson’s
Horsham, PA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Horsham, Pa.; December 14, 2022 — Clinical ink, a global life science technology company, has partnered with a leading …See details»
Contact Support | Clinical ink
United States: 1-800-301-5033. Argentina: 11 5172 5925. Australia: 1 800 248 552 (Toll-Free) Barbados: 1 246 623 9913 844 946 6664 (Toll-Free) Austria: 0800 802 353See details»
Clinical Ink
You have selected to Opt-Out, by clicking Opt-Out you are not agreeing to these terms and will be unable to access Clinical ink's system.See details»
LX Portal | Clinical ink
Log into Clinical ink's LX portal to manage your eCOA study.See details»
Relaunch of Partner Program | Clinical ink
Sep 19, 2022 Will deliver competitive commercial impact via differentiated technological, scientific expertise and operational efficiencies. September 19, 2022 — Today Clinical ink, a …See details»
eConsent for Clinical Trials | Clinical ink
EConsent is the digital process of obtaining informed consent from participants in clinical research. It involves providing comprehensive, user-friendly information about the trial …See details»